RABBIT – Rheumatoide Arthritis: Beobachtung der Biologika-Therapie
RABBIT investigates disease and therapy courses of more than 17,000 patients with rheumatoid arthritis treated by about 400 rheumatologists nationwide. The long-term observation study is conducted by the Pharmacoepidemiology group of the Epidemiology Unit at the German Rheumatism Research Center (Deutsches Rheuma-Forschungszentrum) in Berlin.